Subscribe to this column
Don S. Dizon, MD, FACP, FASCO
Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon.
May 09, 2017
I take my responsibilities as a physician seriously. But when faced with my own sick child, everything on my to-do list—writing, research, even clinic—went out the window.
Apr 27, 2017
When you see enough remarkable recoveries, it becomes tempting to believe it is not only the drugs—that it is you. Where there is the Lazarus effect, perhaps there is the resurgence of the God complex as well.
Mar 31, 2017
When a dying patient wanted more time at any cost, and our team collectively felt that a code would be inhumane, an ethics consultation helped provide clarity and support for our decision-making.
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 02, 2017
When it comes to many alternative therapies, the data is too sparse to inform discussions on benefits and/or risks, as my patient learned when her supplement use prevented her from continuing on a clinical trial.
Latest Blogs